Lee, E. Q., Muzikansky, A., Duda, D. G., Gaffey, S., Dietrich, J., Nayak, L., . . . Wen, P. Y. (2019). Phase II trial of ponatinib in patients with bevacizumab‐refractory glioblastoma. Cancer Med.
Chicago Stili AlıntıLee, Eudocia Q., et al. "Phase II Trial of Ponatinib in Patients With Bevacizumab‐refractory Glioblastoma." Cancer Med 2019.
MLA AlıntıLee, Eudocia Q., et al. "Phase II Trial of Ponatinib in Patients With Bevacizumab‐refractory Glioblastoma." Cancer Med 2019.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..